Clinical trials

Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 270 participants Centre Psychothérapique de Nancy

Clinical High Risk for Psychosis (CHR)

Safety Profile of Psilocybin for Cocaine Use Disorder (opens ClinicalTrials.gov in a new tab)

Suspended Early Phase 1 10 participants University of California, Los Angeles

Cocaine Use Disorder

Psilocybin After Trauma Surgery for Pain (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 70 participants Trent Emerick

Pain Management, Postoperative Pain

Effectiveness of the Mindful Compassion Care Program for Healthcare Professionals in Oncology and Palliative Care (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 160 participants Azienda USL Reggio Emilia - IRCCS

Professional Quality of Life, Palliative Care, Oncology

A Mindfulness-based Intervention for Sexual Assault Survivors (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 120 participants Georgia State University

Alcohol Misuse, Tobacco Use, Mindfulness, Stress

Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 90 participants Massachusetts General Hospital

Repetitive Negative Thinking, Serious Mental Illness Symptoms

Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 60 participants Clive Michelsen

Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders

Mindfulness Therapy for Chronic Pain After Intimate Partner Violence (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 58 participants Brigham and Women's Hospital

Chronic Pain

Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 106 participants University of Sao Paulo

Suicidal Ideation, Suicidal Behavior

Virtual Reality-based Mindfulness Training for Mental Health After Stroke (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 48 participants Nicolas Nicastro

Stroke (Subacute)

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (opens ClinicalTrials.gov in a new tab)

Withdrawn Phase 2 0 participants Johns Hopkins University

Opioid Use Disorder

Mindfulness in Nonflaccid Facial Paralysis (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 24 participants Wake Forest University Health Sciences

Facial Paralysis

The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 80 participants Johns Hopkins University

Psilocybin Intoxication

Online Mindfulness-based Dance/Movement Therapy on Physical Activity and Whole-Person Health in Older Adults (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 204 participants Drexel University

Physical Activity and Wellbeing, Whole Health

Mindful Eating and Mindful Movement for Persons With Type 2 Diabetes Mellitus (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 60 participants Northeastern University

Type 2 Diabetes

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease (opens ClinicalTrials.gov in a new tab)

Recruiting 17 participants City of Hope Medical Center

Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Tirzepatide for the Treatment of Cannabis Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 6 participants Brigham and Women's Hospital

Cannabis Use Disorder

MBI for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 48 participants University of Illinois at Chicago

Chronic Pain, Sickle Cell Disease, Sleep

Psilocybin for Methamphetamine Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 42 participants Peter Hendricks

Methamphetamine Use Disorder

Inhaled Cannabis for Treatment of PTSD (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 320 participants Multidisciplinary Association for Psychedelic Studies

Post Traumatic Stress Disorder PTSD

Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 120 participants University of Wisconsin, Madison

Well-Being, Psychological, Psychedelic Experiences

Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 50 participants Indiana University

Treatment Resistant Depression, Substance Use Disorders

Psilocybin for Depression in Veterans (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 150 participants VA Office of Research and Development

Major Depression

PROGRESS for the Primary Prevention of Early Overweight in Low-income, Rural Families (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 328 participants Penn State University

Childhood Obesity

Effects of Psilocybin on Craving in Nicotine Dependence (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 3 participants University of British Columbia

Nicotine Dependence